chevron_leftBack
As of 24 April 2025, GeneDx Holdings Corp. has a market cap of $2.97B USD, ranking #4150 globally and #1235 in the United States. It ranks #356 in the Healthcare sector, and #31 in the Diagnostics & Research industry.
Key Stats
Market Cap
$2.97BUSD
Enterprise Value
$2.88BUSD
Revenue (TTM)
$305.45MUSD
EBITDA (TTM)
-$408.0KUSD
Net Income (TTM)
-$52.29MUSD
EBITDA Margin
-0.1%
Profit Margin
-17%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Katherine Stueland
open_in_new
Employees
1,000
Founded
2017
Website
genedx.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 9.1% | 7.5% | 1.2% | 39% | 83% | 917% |
Upcoming Earnings
Earnings Date
Wed, Apr 30
Earnings Time
sunny
Before Open
EPS Estimate
$0.1100
Revenue Estimate
$79.9M
28% yoy
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
WGS
GeneDx Holdings Corp Ordinary Shares - Class A
ISIN: US81663L2007
Shares Out.:
Shares Outstanding:
28.068M1
Shares Float:
24.532M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
105.69 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company is headquartered in Stamford, Connecticut.
